With your own knowledge and the help of the following document:

Document 1 (Title: Hematological Manifestations of Infectious and Parasitic Diseases): Anemia represents a common hematological finding across diverse infectious and parasitic conditions through various pathophysiological mechanisms requiring consideration in differential diagnosis and management approaches. Malaria infection demonstrates particularly strong associations with anemia through multiple mechanisms including direct erythrocyte parasitization and hemolysis, dyserythropoiesis from bone marrow suppression, and splenic sequestration of parasitized and non-parasitized erythrocytes. These processes collectively produce anemia of variable severity, with profound hemolytic anemia especially characteristic of Plasmodium falciparum infections involving high parasitemia levels. Similarly, chronic intestinal nematode infections, particularly Strongyloides stercoralis, frequently produce anemia through chronic intestinal blood loss, mucosal inflammation impairing iron absorption, and occasionally through pulmonary hemorrhage during larval migration phases. The magnitude of hematological impact varies with parasite burden, chronicity, and host nutritional status, with profound anemia commonly observed in hyperinfection syndromes. Fungal infections demonstrate variable hematological manifestations, with superficial candidiasis rarely producing significant hematological abnormalities in immunocompetent hosts despite its high prevalence, contrasting with invasive candidiasis in immunocompromised patients, which may involve bone marrow infiltration or trigger immune-mediated cytopenias in complex cases. Trematode infections including Fascioliasis (liver fluke) typically produce minimal direct hematological effects unless complicated by significant biliary obstruction, iron sequestration through chronic inflammation, or hypersplenism from portal hypertension in advanced cases. Protozoan infections beyond malaria, including toxoplasmosis, demonstrate variable hematological manifestations dependent on host immune status, with immunocompetent hosts typically developing mild lymphocytosis rather than significant anemia during acute infection phases.
Document 2 (Title: Clinical Applications of Combined Antimicrobial Agents): Co-trimoxazole represents a widely utilized antimicrobial combination with distinctive pharmacological properties determining its clinical applications and safety considerations. Formulation analysis confirms this agent comprises a fixed combination of sulfamethoxazole and trimethoprim, typically in a 5:1 ratio, creating a synergistic antibacterial effect through sequential inhibition of bacterial folate synthesis. This combination demonstrates particular therapeutic efficacy against Toxoplasma gondii, establishing it as a mainstay treatment for toxoplasmosis across various clinical presentations including cerebral, ocular, and congenital infections. The synergistic mechanism involves sulfamethoxazole inhibition of dihydropteroate synthetase followed by trimethoprim inhibition of dihydrofolate reductase rather than dihydrofolate synthetase, creating a sequential blockade of distinct steps in the folate synthesis pathway. Adverse effect profiles include potentially severe cutaneous reactions ranging from mild rashes to life-threatening conditions including Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell syndrome), particularly in specific risk groups including HIV-infected individuals. Significant drug interactions necessitate careful prescribing considerations, with concurrent methotrexate administration specifically contraindicated due to additive antifolate effects potentially resulting in severe bone marrow suppression and other toxicities. This interaction occurs through both agents affecting folate metabolism through different mechanisms, with trimethoprim inhibiting dihydrofolate reductase activity necessary for methotrexate clearance. The pharmacokinetic profile demonstrates good oral absorption and extensive tissue distribution, including cerebrospinal fluid penetration explaining its utility in central nervous system infections. These characteristics collectively inform appropriate clinical applications, dosing considerations, monitoring requirements, and contraindications for this widely utilized antimicrobial agent across diverse infectious disease scenarios.
Document 3 (Title: Parasitology and Management of Enterobius vermicularis Infection): Enterobius vermicularis (pinworm) infection represents a common helminthic condition with distinctive clinical and epidemiological characteristics requiring accurate understanding for appropriate diagnosis and management. The parasitic lifecycle demonstrates several notable features influencing clinical presentation and treatment approaches. Following ingestion of infective eggs, larval development progresses relatively rapidly through the gastrointestinal tract, with mature female worms typically beginning egg deposition within 4-6 weeks of initial infection rather than extended 3-month maturation periods documented with certain other helminthic species. Egg deposition occurs primarily through nocturnal migration of female worms to the perianal region, creating the characteristic pruritus ani that often prompts medical attention. Pulmonary involvement including Löffler's syndrome (transient pulmonary infiltrates with eosinophilia) represents a potential manifestation of certain tissue-migrating helminthic infections but characteristically does not occur during pinworm infection due to its non-migratory lifecycle confined to the intestinal lumen. Hematological assessment typically reveals minimal abnormalities, though mild eosinophilia (5-15%) may occasionally develop in some cases, particularly with heavy parasite burdens or prolonged infection. Diagnostic approaches focus on detection of characteristic eggs through adhesive tape preparations rather than direct visualization of adult worms, which remain predominantly within the intestinal lumen rather than being evacuated through the oral route, distinguishing this infection from certain other parasitic conditions where adult worm passage may occur. Treatment typically involves benzimidazole compounds including mebendazole and albendazole, with flubendazole representing an alternative therapeutic option in some geographical regions. Comprehensive management includes treating household contacts and environmental measures addressing potential fomite transmission through bedding and clothing.

Answer the following list question.
Question: In which of the following diseases can anemia be observed?
Options:
1. Candidiasis
2. Malaria
3. Fascioliasis
4. Strongyloidiasis
5. Toxoplasmosis

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ← if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.